Related Experiment Video
Updated: Aug 3, 2026
10:43
Expression, Detergent Solubilization, and Purification of a Membrane Transporter, the MexB Multidrug Resistance Protein
Published on: December 3, 2010
Structural Analysis and New Drug Development against Multidrug Efflux Pumps
Seiji Yamasaki1, Ryosuke Nakashima, Keisuke Sakurai
1Institute of Scientific and Industrial Research, Osaka University.
Summary
Researchers identified structural differences between MexB and MexY multidrug efflux pumps. This discovery enables the design of new inhibitors to combat Gram-negative pathogen resistance.
Area of Science:
- Microbiology
- Structural Biology
- Drug Discovery
Background:
- Multidrug efflux pumps confer resistance in Gram-negative pathogens.
- Current efflux pump inhibitors lack clinical utility.
- MexB and MexY are key efflux pumps in Pseudomonas aeruginosa.
Purpose of the Study:
- To elucidate the structural basis for differential inhibition of MexB and MexY efflux pumps.
- To guide the development of novel, clinically useful efflux pump inhibitors.
Main Methods:
- Determined inhibitor-bound structures of MexB and MexY efflux pumps.
- Utilized structural information to design and synthesize novel inhibitor compounds.
- Assessed the inhibitory activity of designed compounds against bacterial strains.
Main Results:
- ABI-PP binds to a specific pit in MexB, hindering its function.
- Structural differences, specifically amino acid residues (phenylalanine in MexB vs. tryptophan in MexY), dictate inhibitor binding.
- Designed compounds effectively inhibited both MexB and MexY pumps, preventing bacterial growth.
Conclusions:
- Structural insights into efflux pump inhibitor binding are crucial for drug development.
- Targeting specific binding pockets can overcome resistance mechanisms.
- Novel inhibitors targeting MexB and MexY show promise for clinical application against multidrug-resistant pathogens.
More Related Videos
Related Concept Videos
01:19Drug Absorption Mechanism: Carrier-Mediated Membrane Transport
Certain large, lipid-insoluble drug molecules that resemble amino acids, peptides, or glucose, require specialized carrier proteins to facilitate their diffusion across cell membranes. This transport can occur through either facilitated diffusion, which does not require energy input, or active transport, which does require energy input.
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
01:28Structure-Activity Relationships and Drug Design
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
01:24Cellular Membranes and Drug Transport
Drugs must traverse multiple biological barriers, such as multi-layered skin, single-layered intestinal epithelium, and the plasma membrane, to reach their target sites within the body. The plasma membrane, a highly structured composite of phospholipids, carbohydrates, and proteins, is the cell's protective boundary, facilitating selective substance exchange.
Phospholipids arrange themselves into a bilayer, with hydrophilic heads oriented outward and hydrophobic tails facing inward.
Phospholipids arrange themselves into a bilayer, with hydrophilic heads oriented outward and hydrophobic tails facing inward.
01:23Mechanisms of Drug Absorption: Paracellular, Transcellular, and Vesicular Transport
Drugs need to permeate cell membranes to reach their target sites after administration. Orally administered drugs must transcend intestinal epithelial membrane barriers to infiltrate the systemic circulation. Drugs with a molecular weight of less than 500 Daltons diffuse through gaps between neighboring cells, called paracellular pathways.
However, most drugs use the transcellular route, traversing directly through the cell membranes via two mechanisms: passive and active transport. Passive...
However, most drugs use the transcellular route, traversing directly through the cell membranes via two mechanisms: passive and active transport. Passive...
01:17Pore Transport and Ion-Pair Transport
Pore transport and ion-pair formation are critical mechanisms for the absorption and distribution of drugs in the body.
Pore transport, also known as convective transport, is a process where small molecules like urea, water, and sugars rapidly cross cell membranes as though there were channels or pores in the membrane. Although direct microscopic evidence is limited but the concept of pores or channels is widely accepted based on physiological evidence. Despite the lack of direct microscopic...
Pore transport, also known as convective transport, is a process where small molecules like urea, water, and sugars rapidly cross cell membranes as though there were channels or pores in the membrane. Although direct microscopic evidence is limited but the concept of pores or channels is widely accepted based on physiological evidence. Despite the lack of direct microscopic...
01:06Carrier-Mediated Transport
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...